Teva Canada Innovation et al. v. Apotex Inc. et al., 2014 FC 1070
| Judge | Gleason, J. |
| Court | Federal Court (Canada) |
| Case Date | December 19, 2014 |
| Jurisdiction | Canada (Federal) |
| Citations | 2014 FC 1070 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
17 practice notes
-
Eli Lilly Canada Inc. v. Apotex Inc. et al., 2015 FC 875
...SCC 66 , refd to. [para. 105]. Teva Canada Innovation et al. v. Apotex Inc. et al., [2015] F.T.R. TBEd. AP.034 ; 252 A.C.W.S.(3d) 322 ; 2014 FC 1070, dist. [para. AstraZeneca Canada Inc. et al. v. Apotex Inc. et al. (2014), 457 F.T.R. 227 ; 244 A.C.W.S.(3d) 180 ; 2014 FC 638 , affd. (......
-
Gilead Sciences, Inc. v. Canada (Health), 2016 FC 856
...and refers to: AstraZeneca Canada Inc v Apotex Inc, 2014 FC 638 , per Rennie J, at para 321; Teva Canada Innovation v Apotex Inc, 2014 FC 1070, per Gleason J (as she then was), at paras 94-96; Takeda Canada Inc. v Canada (Health), 2015 FC 570 , per O’Reilly J, at paras 27, 29; Allergan In......
-
Gemak Trust v. Jempak Corporation, 2022 FCA 141
... 2009 FC 676 at para. 66; Lundbeck Canada Inc. v. Canada (Health), 2009 FC 146 at para. 11; Teva Canada Innovation v. Apotex Inc., 2014 FC 1070 at para. 109; Apotex Inc. v. Shire LLC, 2017 FC 139 at para. 39; Amgen Canada Inc. v. Apotex Inc., 2015 FC 1261 at para. 15 (Amgen); Novarti......
-
Seedlings Life Science Ventures, LLC v. Pfizer Canada ULC, 2020 FC 505
...done in other patent cases (Eli Lilly Canada Inc v Apotex Inc, 2015 FC 1165 at paragraph 18; see also Teva Canada Innovation v Apotex Inc, 2014 FC 1070 at paragraph 116, and ABB Technology at paragraph 10). [29] Seedlings seeks to have Dr. Meyer’s total amount claimed reduced because (1) sh......
Request a trial to view additional results
12 cases
-
Eli Lilly Canada Inc. v. Apotex Inc. et al., 2015 FC 875
...SCC 66 , refd to. [para. 105]. Teva Canada Innovation et al. v. Apotex Inc. et al., [2015] F.T.R. TBEd. AP.034 ; 252 A.C.W.S.(3d) 322 ; 2014 FC 1070, dist. [para. AstraZeneca Canada Inc. et al. v. Apotex Inc. et al. (2014), 457 F.T.R. 227 ; 244 A.C.W.S.(3d) 180 ; 2014 FC 638 , affd. (......
-
Gilead Sciences, Inc. v. Canada (Health), 2016 FC 856
...and refers to: AstraZeneca Canada Inc v Apotex Inc, 2014 FC 638 , per Rennie J, at para 321; Teva Canada Innovation v Apotex Inc, 2014 FC 1070, per Gleason J (as she then was), at paras 94-96; Takeda Canada Inc. v Canada (Health), 2015 FC 570 , per O’Reilly J, at paras 27, 29; Allergan In......
-
Gemak Trust v. Jempak Corporation, 2022 FCA 141
... 2009 FC 676 at para. 66; Lundbeck Canada Inc. v. Canada (Health), 2009 FC 146 at para. 11; Teva Canada Innovation v. Apotex Inc., 2014 FC 1070 at para. 109; Apotex Inc. v. Shire LLC, 2017 FC 139 at para. 39; Amgen Canada Inc. v. Apotex Inc., 2015 FC 1261 at para. 15 (Amgen); Novarti......
-
Seedlings Life Science Ventures, LLC v. Pfizer Canada ULC, 2020 FC 505
...done in other patent cases (Eli Lilly Canada Inc v Apotex Inc, 2015 FC 1165 at paragraph 18; see also Teva Canada Innovation v Apotex Inc, 2014 FC 1070 at paragraph 116, and ABB Technology at paragraph 10). [29] Seedlings seeks to have Dr. Meyer’s total amount claimed reduced because (1) sh......
Request a trial to view additional results
5 firm's commentaries
-
Pharma In Brief - Blinded Expert Evidence Favoured: Court Dismisses PM(NOC) Application For Ciclesonide
...has gained favour in other cases: AstraZeneca Canada Inc. v. Apotex Inc., 2014 FC 638 at para. 321; Teva Canada Innovation v. Apotex Inc., 2014 FC 1070 at para. 94." Link to decision: Takeda Canada Inc. and Takeda GMBH v The Minister of Health and Apotex Inc., 2015 FC 570 Norton Rose Fulbri......
-
Pharma In Brief - Generic v. Generic PM(NOC) Application Dismissed For Non-Infringement
...Teva Canada Innovation and Teva Pharmaceutical Industries Ltd. v. Apotex Inc., 2014 FC 1070 Drug: AZILECT® Nature of case: Section 6 prohibition proceedings under the PM(NOC) Regulations Successful party: Apotex Inc. Date of decision: December 19, 2014 (Public Judgment and Reasons); Novembe......
-
Formulation Patent Found Not To Be Infringed As A Redacted Excipient Was Not A 'Pentahydric Or Hexahydric Alcohol' (Intellectual Property Weekly Abstracts Bulletin (Week Of April 20 2015))
...Excipient Was Not a "Pentahydric or Hexahydric Alcohol" Teva Canada Innovation and Teva Pharmaceutical Industries Ltd. v. Apotex Inc., 2014 FC 1070 Drug: rasagiline Apotex has successfully alleged that Teva's patent to "Stable Compositions Containing [Rasagiline]" will not be infringed by A......
-
Formulation Patent Found Not To Be Infringed As A Redacted Excipient Was Not A 'Pentahydric Or Hexahydric Alcohol' (Intellectual Property Weekly Abstracts Bulletin (Week Of April 20, 2015)
...Excipient Was Not a "Pentahydric or Hexahydric Alcohol" Teva Canada Innovation and Teva Pharmaceutical Industries Ltd. v. Apotex Inc., 2014 FC 1070 Drug: rasagiline Apotex has successfully alleged that Teva's patent to "Stable Compositions Containing [Rasagiline]" will not be infringed by A......
Request a trial to view additional results